Open AccessPB2005: BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: A REAL‐WORLD STUDY OF CHINA
Author(s) -
Jingyu X.,
Wenqiang Y.,
Huishou F.,
Jiahui L.,
Lingna L.,
Lugui Q.,
Gang A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850852.33643.f0
Subject(s) - lenalidomide , medicine , multiple myeloma , bortezomib , oncology , autologous stem cell transplantation , dexamethasone , minimal residual disease , regimen , hematopoietic stem cell transplantation , transplantation , thalidomide , surgery , bone marrow